Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma

Erica K. Barnell(Washington University in St. Louis), Lukas D. Wartman(MACOM (United States)), Marianna B. Ruzinova(Washington University in St. Louis), Kelsy C. Cotto(James S. McDonnell Foundation), Daniel Kohnen(Washington University in St. Louis), Mark A. Fiala(Washington University in St. Louis), Ravi Vij(Washington University in St. Louis), John L. Frater(Washington University in St. Louis), Malachi Griffith(Washington University in St. Louis), Zachary L. Skidmore(James S. McDonnell Foundation), Friederike Kreisel(Saint Louis University), Katie M. Campbell(University of California, Los Angeles), Monique Chavez(Washington University in St. Louis), Nicholas C. Spies(James S. McDonnell Foundation), Justin King(Washington University in St. Louis), Eric J. Duncavage(Washington University in St. Louis), Bijal A. Parikh(Washington University in St. Louis), Brooj Abro(Washington University in St. Louis), Kenneth F. Newcomer(Washington University in St. Louis), John S. Welch(Washington University in St. Louis), Tianjiao Wang(Washington University in St. Louis), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Anjum Hassan(Washington University in St. Louis), Kiran Vij(Washington University in St. Louis), Yi-Shan Lee(National Taipei University of Technology), Obi L. Griffith(Washington University in St. Louis)

Blood Advances

October 17, 2022

Cited by 19

|Nature|2012|2k

|New England Journal of Medicine|2018|1.4k

|New England Journal of Medicine|2012|1.1k

|Science Translational Medicine|2016|916

|New England Journal of Medicine|2016|783

Related Papers